<DOC>
	<DOCNO>NCT01725412</DOCNO>
	<brief_summary>Thiamine key component creation physiologic anti-inflammatory mediator . Serum thiamine store find deficient diabetic patient . Thiamine deficiency may key pathological mechanism inflammation result diabetic kidney retinal injury . The investigator hypothesize repletion patient 's thiamine oral supplementation may result reduce inflammation , therefore reduce kidney injury .</brief_summary>
	<brief_title>Prevention Renal Complications Diabetes With Thiamine</brief_title>
	<detailed_description>Thiamine ( vitamin B1 ) water-soluble vitamin . It absorb gastrointestinal tract take tissue transport protein convert thiamine pyrophosphate ( TPP ) thiamine pyrophosphokinase ( TPPK ) . TPP co-factor pyruvate dehydrogenase ( PDH ) , α-ketoglutarate dehydrogenase transketolase ( TKT ) —enzymes involved metabolism glucose . Various transport protein involve transport thiamine monophosphate ( TMP ) TPP across membrane . These include thiamine transport isoform-1 ( THTR1 ) thiamine transporter isoform-2 ( THTR2 ) , reduced folate carrier-1 ( RFC-1 ) , transport TMP TPP across cell plasma membrane mitochondrial TPP transporter ( mTHTR ) . Thiamine TMP/TPP transporter may abnormal expression diabetes . Increased THTR1 level find red blood cell ( RBCs ) mononuclear leucocytes patient diabetes compare healthy subject . RBC precursor leucocytes appear up-regulate THTR1 expression response decrease thiamine availability . In presence hyperglycemia , renal tubular epithelial cell , contrast , decrease expression . In experimental model diabetes human diabetic increase clearance thiamine demonstrate . This precede development microalbuminuria . Patients microalbuminuria early decline glomerular filtration rate high fractional excretion thiamine compare patient stable renal function . Thiamine supplementation STZ- diabetic mouse prevent development microalbuminuria , decrease urinary albumin excretion ( UAE ) approximately 80 % . In addition thiamine supplementation prevent diuresis glycosuria . Human study limit one placebo control study thiamine group show significant decrease microalbuminuria diabetic patient thiamine .</detailed_description>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Thiamine</mesh_term>
	<criteria>diagnosis Type II diabetes present least 5 year , persistent microalbuminuria ( 30299 mg/24 h ) , HbA1c ≤ 8 % , BMI 1940 kg/m2 . significant comorbidities , `` deficient renal function '' know allergy intolerance thiamine , use thiamine supplement , participation interventional study within 30 day , recipient renal and/or pancreatic transplant woman pregnant breast feeding .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>